Patent ID: 8299218

Claim:
An isolated antibody, or antigen-binding fragment thereof, that specifically binds to an epitope of Botulinum neurotoxin type A, wherein the antibody or antigen-binding fragment comprises: a) a VL CDR1 comprising the amino acid sequence of SEQ ID NO:165; b) a VL CDR2 comprising the amino acid sequence of SEQ ID NO:167; c) a VL CDR3 comprising the amino acid sequence of SEQ ID NO:203; and d) VH CDRs comprising: i) a VH CDR1 comprising the amino acid sequence of SEQ ID NO:91; ii) a VH CDR2 comprising the amino acid sequence of SEQ ID NO:93; and ii) a VH CDR3 comprising the amino acid sequence of SEQ ID NO:130; or i) a VH CDR1 comprising the amino acid sequence of SEQ ID NO:95; ii) a VH CDR2 comprising the amino acid sequence of SEQ ID NO:97; and ii) a VH CDR3 comprising the amino acid sequence of SEQ ID NO:133.